Veterans Affairs Cooperative Studies Program study...[Urology. 2008] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Click to change filter selection through MyNCBI.

1: Urology. 2008 Sep;72(3):474-80. Epub 2008 Apr 14. Links

Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer.

Montgomery B, Lavori P, Garzotto M, Lee K, Brophy M, Thaneemit-Chen S, Kelly W, Basler J, Ringer R, Yu W, Whittemore A, Lin DW.

Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington 98109, USA. rbmontgo@u.washington.edu

PMID: 18407333 [PubMed - indexed for MEDLINE]

Related articles

Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
Urology. 2003 Dec 29; 62 Suppl 1:55-62.

[Urology. 2003]
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
J Urol. 2007 May; 177(5):1777-81.

[J Urol. 2007]
High-risk localized prostate cancer: integrating chemotherapy.
Oncologist. 2005 Oct; 10 Suppl 2:18-22.

[Oncologist. 2005]
ReviewHigh-risk localized prostate cancer: primary surgery and adjuvant therapy.
Urol Oncol. 2003 May-Jun; 21(3):219-27.

[Urol Oncol. 2003]
ReviewAdjuvant goserelin improves clinical disease-free survival and reduces disease-related mortality in patients with locally advanced or localized prostate cancer.
BJU Int. 2004 Jan; 93(1):42-6.

[BJU Int. 2004]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, ...Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show